Cargando…
A High-Throughput Assay for Small Molecule Destabilizers of the KRAS Oncoprotein
Mutations in the Ras family of small GTPases, particularly KRAS, occur at high frequencies in cancer and represent a major unmet therapeutic need due to the lack of effective targeted therapies. Past efforts directed at inhibiting the activity of the Ras oncoprotein have proved difficult. We propose...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122376/ https://www.ncbi.nlm.nih.gov/pubmed/25093678 http://dx.doi.org/10.1371/journal.pone.0103836 |
_version_ | 1782329340690694144 |
---|---|
author | Carver, Joseph Dexheimer, Thomas S. Hsu, Dennis Weng, Meng-Tzu Smith, Jordan L. Guha, Rajarshi Jadhav, Ajit Simeonov, Anton Luo, Ji |
author_facet | Carver, Joseph Dexheimer, Thomas S. Hsu, Dennis Weng, Meng-Tzu Smith, Jordan L. Guha, Rajarshi Jadhav, Ajit Simeonov, Anton Luo, Ji |
author_sort | Carver, Joseph |
collection | PubMed |
description | Mutations in the Ras family of small GTPases, particularly KRAS, occur at high frequencies in cancer and represent a major unmet therapeutic need due to the lack of effective targeted therapies. Past efforts directed at inhibiting the activity of the Ras oncoprotein have proved difficult. We propose an alternative approach to target Ras by eliminating Ras protein from cells with pharmacological means. In this study, we developed a cell-based, high-content screening platform to identify small molecules that could promote the degradation of the KRAS oncoprotein. We generated an EGFP-KRAS(G12V) fluorescence reporter system and implemented it for automated screening in 1536-well plates using high-throughput cellular imaging. We screened a library of clinically relevant compounds at wide dose range and identified Ponatinib and AMG-47a as two candidate compounds that selectively reduced the levels of EGFP-KRAS(G12V) protein but did not affect EGFP protein in cells. This proof-of-principle study demonstrates that it is feasible to use a high-throughput screen to identify compounds that promote the degradation of the Ras oncoprotein as a new approach to target Ras. |
format | Online Article Text |
id | pubmed-4122376 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-41223762014-08-12 A High-Throughput Assay for Small Molecule Destabilizers of the KRAS Oncoprotein Carver, Joseph Dexheimer, Thomas S. Hsu, Dennis Weng, Meng-Tzu Smith, Jordan L. Guha, Rajarshi Jadhav, Ajit Simeonov, Anton Luo, Ji PLoS One Research Article Mutations in the Ras family of small GTPases, particularly KRAS, occur at high frequencies in cancer and represent a major unmet therapeutic need due to the lack of effective targeted therapies. Past efforts directed at inhibiting the activity of the Ras oncoprotein have proved difficult. We propose an alternative approach to target Ras by eliminating Ras protein from cells with pharmacological means. In this study, we developed a cell-based, high-content screening platform to identify small molecules that could promote the degradation of the KRAS oncoprotein. We generated an EGFP-KRAS(G12V) fluorescence reporter system and implemented it for automated screening in 1536-well plates using high-throughput cellular imaging. We screened a library of clinically relevant compounds at wide dose range and identified Ponatinib and AMG-47a as two candidate compounds that selectively reduced the levels of EGFP-KRAS(G12V) protein but did not affect EGFP protein in cells. This proof-of-principle study demonstrates that it is feasible to use a high-throughput screen to identify compounds that promote the degradation of the Ras oncoprotein as a new approach to target Ras. Public Library of Science 2014-08-05 /pmc/articles/PMC4122376/ /pubmed/25093678 http://dx.doi.org/10.1371/journal.pone.0103836 Text en © 2014 Carver et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Carver, Joseph Dexheimer, Thomas S. Hsu, Dennis Weng, Meng-Tzu Smith, Jordan L. Guha, Rajarshi Jadhav, Ajit Simeonov, Anton Luo, Ji A High-Throughput Assay for Small Molecule Destabilizers of the KRAS Oncoprotein |
title | A High-Throughput Assay for Small Molecule Destabilizers of the KRAS Oncoprotein |
title_full | A High-Throughput Assay for Small Molecule Destabilizers of the KRAS Oncoprotein |
title_fullStr | A High-Throughput Assay for Small Molecule Destabilizers of the KRAS Oncoprotein |
title_full_unstemmed | A High-Throughput Assay for Small Molecule Destabilizers of the KRAS Oncoprotein |
title_short | A High-Throughput Assay for Small Molecule Destabilizers of the KRAS Oncoprotein |
title_sort | high-throughput assay for small molecule destabilizers of the kras oncoprotein |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122376/ https://www.ncbi.nlm.nih.gov/pubmed/25093678 http://dx.doi.org/10.1371/journal.pone.0103836 |
work_keys_str_mv | AT carverjoseph ahighthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein AT dexheimerthomass ahighthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein AT hsudennis ahighthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein AT wengmengtzu ahighthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein AT smithjordanl ahighthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein AT guharajarshi ahighthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein AT jadhavajit ahighthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein AT simeonovanton ahighthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein AT luoji ahighthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein AT carverjoseph highthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein AT dexheimerthomass highthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein AT hsudennis highthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein AT wengmengtzu highthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein AT smithjordanl highthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein AT guharajarshi highthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein AT jadhavajit highthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein AT simeonovanton highthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein AT luoji highthroughputassayforsmallmoleculedestabilizersofthekrasoncoprotein |